Table 2.
Details of antibodies used
| Antibodies | Supplier | Dilution | Application |
|---|---|---|---|
| C1Q | Dako (R) | 1:5000 | W |
| C1R | MP (G) | 1:5000 | W |
| C1S | MP (G) | 1:5000 | W |
| C2 | ART (G) | 1:5000 | W |
| C3 | ART (G) | 1:10,000 | W |
| C4 | ART (G) | 1:10,000 | W |
| C5 | ART (G) | 1:5000 | W |
| C6 | ART (G) | 1:5000 | W |
| C7 | ART (G) | 1:5000 | W |
| C8 | ART (G) | 1:10,000 | W |
| C9 | ART (G) | 1:5000 | W |
| SMA | Sigma (M) | 1:5000 | ICC |
| CD31 | Dako (M) | 1:1000 | ICC |
| LN3 | MP (M) | 1:500 | ICC |
| GFAP | Dako (R) | 1:2000 | ICC |
Abbreviations: Dako; Dako North America, Carpinteria, CA: MP; MP Biomedicals, Solon, OH: ART; Advanced Research Technologies, San Diego, CA; Sigma; Sigma Chemical Company, St. Louis,MO: (R), rabbit polyclonal: (G), goat polyclonal: (M), mouse monoclonal: W, western blots: ICC; immunocytochemistry: SMA, smooth muscle α-actin